This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.scitotenv.2016.12.070 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of principal component analysis algorithms for imputation in agrometeorological data in high dimension and reduced sample size.
PLoS One
December 2024
São Paulo State University (Unesp), School of Sciences and Engineering, Tupã, São Paulo, Brasil.
Meteorological data acquired with precision, quality, and reliability are crucial in various agronomy fields, especially in studies related to reference evapotranspiration (ETo). ETo plays a fundamental role in the hydrological cycle, irrigation system planning and management, water demand modeling, water stress monitoring, water balance estimation, as well as in hydrological and environmental studies. However, temporal records often encounter issues such as missing measurements.
View Article and Find Full Text PDFPredicting the toxic side effects of drug interactions using chemical structures and protein sequences.
Sci Rep
December 2024
School of Public Health, Chongqing Medical University, 1 Yixueyuan Road, Yuzhong District, Chongqing, 400016, China.
The study aims to address the critical issue of toxic side effects resulting from drug combinations, which can significantly increase health risks, clinical complications, and lead to drug being withdrawn from the market. A model named TSEDDI (toxic side effects of drug-drug interaction) has been developed to improve the identification of drug pairs that may induce toxicity or adverse reactions. By utilizing drug chemical structures and diverse proteins, we employ a convolutional neural network (CNN) to extract features from molecular images, enzyme proteins, transporter proteins, and target proteins.
View Article and Find Full Text PDFBarnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study.
Clin Rheumatol
December 2024
Rheumatology Unit, Department of Medicine, University of Verona, P.le L.A. Scuro 10, 37134, Verona, Italy.
Objectives: To assess short-term barnidipine efficacy and tolerability on Systemic Sclerosis (SSc)-Raynaud's phenomenon (RP).
Methods: We retrospectively evaluated patients with SSc starting barnidipine 10 mg/day. Raynaud's Condition Score (RCS) and mean blood pressure (MBP) were assessed at baseline and 6-month follow-up.
Background: As bronchiectasis progresses, increasing degrees of airflow limitation can occur.
Objectives: This study aimed to investigate whether concomitant airflow limitation was associated with poor prognosis in patients with bronchiectasis and to identify the characteristics of patients with airflow limitation in bronchiectasis.
Design: A prospective longitudinal study was conducted to determine the characteristics and prognosis of bronchiectasis patients with airflow limitation.
Identification of constitutive law for 3d-printed bioresorbable thermosensitive polymer to design medical devices for soft tissue reconstruction.
Comput Methods Biomech Biomed Engin
November 2024
Univ. Lille, CNRS, Centrale Lille, UMR 9013 - LaMcube - Laboratoire de Mécanique, Multiphysique, Multiéchelle, Lille, France.
Breast cancer concerns 1 in 8 women in the world and is followed in 40% of cases by a mastectomy. Only 14% of women receive reconstructive surgery because of unfavorable clinical issues. The need of innovative tissue engineering devices leads Lattice Medical company to bring a new 3D-printed device, allowing the regeneration of soft tissue in order to replace the withdrawn breast.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!